|
LIMA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.688000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.295400E-01 |
| Normal-vs-Stage2 |
6.255400E-03 |
| Normal-vs-Stage3 |
6.119800E-01 |
| Normal-vs-Stage4 |
5.127400E-01 |
| Stage1-vs-Stage2 |
9.461100E-03 |
| Stage1-vs-Stage3 |
4.123800E-01 |
| Stage1-vs-Stage4 |
6.850600E-01 |
| Stage2-vs-Stage3 |
4.939400E-03 |
| Stage2-vs-Stage4 |
5.619600E-02 |
| Stage3-vs-Stage4 |
3.142200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.315000E-01 |
| Normal-vs-AfricanAmerican |
3.279400E-01 |
| Normal-vs-Asian |
7.013800E-01 |
| Caucasian-vs-AfricanAmerican |
2.965200E-01 |
| Caucasian-vs-Asian |
5.643600E-01 |
| AfricanAmerican-vs-Asian |
5.281000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.842600E-01 |
| Normal-vs-Female |
7.174200E-01 |
| Male-vs-Female |
5.138800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.970000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.290000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.001400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.335800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.108550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.887580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.050000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.582200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.537200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.035200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.626300E-02 |
| Classical-VS-Follicular |
5.14590037248297E-10 |
| Classical-VS-Other |
3.999000E-01 |
| Classical-VS-Normal |
4.997200E-01 |
| Tall-VS-Follicular |
5.65339999999415E-05 |
| Tall-VS-Other |
1.268970E-01 |
| Tall-VS-Normal |
2.364000E-02 |
| Follicular-VS-Other |
1.988390E-01 |
| Follicular-VS-Normal |
1.4009000000037E-06 |
| Other-VS-Normal |
4.157600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.212200E-02 |
| Normal-vs-N1 |
3.139200E-01 |
| N0-vs-N1 |
7.575800E-01 |
|
|
